Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Cardiovascular Risk Factors and Secondary Events Among Acute and Chronic Stable Myocardial Infarction Patients: Findings from a Managed Care Database.

Bash LD, White K, Patel MD, Liu J, Mavros P, Mahaffey KW.

Cardiol Ther. 2019 Aug 20. doi: 10.1007/s40119-019-00147-5. [Epub ahead of print]

PMID:
31432429
2.

Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study.

Saager L, Maiese EM, Bash LD, Meyer TA, Minkowitz H, Groudine S, Philip BK, Tanaka P, Gan TJ, Rodriguez-Blanco Y, Soto R, Heisel O.

J Clin Anesth. 2019 Aug;55:33-41. doi: 10.1016/j.jclinane.2018.12.042. Epub 2018 Dec 27.

PMID:
30594097
3.

Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe.

Ferrieres J, De Ferrari GM, Hermans MP, Elisaf M, Toth PP, Horack M, Brudi P, Lautsch D, Bash LD, Baxter CA, Ashton V, Ambegaonkar B, Gitt AK.

Eur J Prev Cardiol. 2018 Dec;25(18):1966-1976. doi: 10.1177/2047487318806359. Epub 2018 Oct 18.

PMID:
30335504
4.

International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee.

Mok Y, Ballew SH, Bash LD, Bhatt DL, Boden WE, Bonaca MP, Carrero JJ, Coresh J, D'Agostino RB Sr, Elley CR, Fowkes FGR, Jee SH, Kovesdy CP, Mahaffey KW, Nadkarni G, Peterson ED, Sang Y, Matsushita K.

J Am Heart Assoc. 2018 Jul 7;7(14). pii: e008426. doi: 10.1161/JAHA.117.008426.

5.

Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study.

Ferrières J, Lautsch D, Ambegaonkar BM, De Ferrari GM, Vyas A, Baxter CA, Bash LD, Velkovski-Rouyer M, Horack M, Almahmeed W, Chiang FT, Poh KK, Elisaf M, Brudi P, Gitt AK.

Int J Cardiol. 2018 Nov 1;270:21-27. doi: 10.1016/j.ijcard.2018.06.008. Epub 2018 Jun 6.

6.

Contemporary data on treatment practices for low-density lipoprotein cholesterol in 6794 patients with stable coronary heart disease across the world.

Gitt AK, Lautsch D, Ferrières J, De Ferrari GM, Vyas A, Baxter CA, Bash LD, Ashton V, Horack M, Almahmeed W, Chiang FT, Poh KK, Brudi P, Ambegaonkar B.

Data Brief. 2018 May 1;18:1937-1940. doi: 10.1016/j.dib.2018.04.092. eCollection 2018 Jun.

7.

External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction.

Williams BA, Chagin KM, Bash LD, Boden WE, Duval S, Fowkes FGR, Mahaffey KW, Patel MD, D'Agostino RB, Peterson ED, Kattan MW, Bhatt DL, Bonaca MP.

Atherosclerosis. 2018 May;272:80-86. doi: 10.1016/j.atherosclerosis.2018.03.026. Epub 2018 Mar 16.

PMID:
29579671
8.

How does the TRS 2°P score relate to real-world patients?

Bonaca MP, De Ferrari GM, Atar D, Bash LD, Lautsch D, Bohula EA, Horack M, Brudi P, Ferrieres J, Gitt AK.

Eur Heart J Cardiovasc Pharmacother. 2018 Apr 1;4(2):72-74. doi: 10.1093/ehjcvp/pvy004. No abstract available.

9.

Contemporary data on treatment practices for low-density lipoprotein cholesterol in 3867 patients who had suffered an acute coronary syndrome across the world.

Gitt AK, Lautsch D, Ferrières J, De Ferrari GM, Vyas A, Baxter CA, Bash LD, Ashton V, Horack M, Almahmeed W, Chiang FT, Poh KK, Brudi P, Ambegaonkar B.

Data Brief. 2017 Nov 14;16:369-375. doi: 10.1016/j.dib.2017.11.034. eCollection 2018 Feb.

10.

Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.

Gitt AK, Lautsch D, Ferrières J, De Ferrari GM, Vyas A, Baxter CA, Bash LD, Ashton V, Horack M, Almahmeed W, Chiang FT, Poh KK, Brudi P, Ambegaonkar B.

Atherosclerosis. 2017 Nov;266:158-166. doi: 10.1016/j.atherosclerosis.2017.08.013. Epub 2017 Aug 21.

PMID:
29028484
11.

Changes in Treatment Patterns and Incremental Health Care Utilization Due to P2Y12-Associated Complications in Patients with Acute Coronary Syndrome.

Vyas A, Bash LD, Patel MD, Simpson RJ Jr.

J Manag Care Spec Pharm. 2017 Sep;23(9):947-956. doi: 10.18553/jmcp.2017.23.9.947.

12.

Comprehensive healthcare resource use among newly diagnosed congestive heart failure.

Bash LD, Weitzman D, Blaustein RO, Sharon O, Shalev V, Chodick G.

Isr J Health Policy Res. 2017 Jun 5;6:26. doi: 10.1186/s13584-017-0149-0. eCollection 2017.

13.

Differences in short and long-term survival between males and females with new-onset heart failure: A retrospective cohort study.

Chodick G, Weitzman D, Blaustein RO, Shalev V, Bash LD.

Eur J Intern Med. 2017 Jun;41:e21-e23. doi: 10.1016/j.ejim.2017.03.010. Epub 2017 Mar 20. No abstract available.

PMID:
28336125
14.
15.

Hypertension control and antihypertensive therapy in patients with chronic kidney disease.

Unni S, White K, Goodman M, Ye X, Mavros P, Bash LD, Brixner D.

Am J Hypertens. 2015 Jun;28(6):814-22. doi: 10.1093/ajh/hpu215. Epub 2014 Nov 24.

PMID:
25421796
16.

Prevalence of lipid abnormalities and attainment of normal lipid levels among patients with dyslipidaemia: a pooled analysis of observational studies from five Asian countries.

Unniachan S, Bash LD, Khovidhunkit W, Sri RZ, Vicaldo E, Recto C 2nd, Ambegaonkar BM.

Int J Clin Pract. 2014 Aug;68(8):1010-9. doi: 10.1111/ijcp.12407. Epub 2014 Mar 25.

PMID:
24666791
17.

Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study.

Crijns HJ, Weijs B, Fairley AM, Lewalter T, Maggioni AP, Martín A, Ponikowski P, Rosenqvist M, Sanders P, Scanavacca M, Bash LD, Chazelle F, Bernhardt A, Gitt AK, Lip GY, Le Heuzey JY.

Int J Cardiol. 2014 Apr 1;172(3):588-94. doi: 10.1016/j.ijcard.2014.01.099. Epub 2014 Jan 25.

18.

Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the RHYTHM-AF study).

Lip GY, Gitt AK, Le Heuzey JY, Bash LD, Morabito CJ, Bernhardt AA, Sisk CM, Chazelle F, Crijns HJ; RHYTHM-AF Scientific Committee.

Am J Cardiol. 2014 Feb 1;113(3):480-4. doi: 10.1016/j.amjcard.2013.10.036. Epub 2013 Nov 9.

PMID:
24332698
19.

Attainment of normal lipid levels among high cardiovascular risk patients: pooled analysis of observational studies from the United Kingdom, Sweden, Spain and Canada.

Ambegaonkar BM, Bash LD, Chirovsky DR, Jameson K, Grant S, Nocea G, Pettersson B, Sazonov V.

Eur J Intern Med. 2013 Oct;24(7):656-63. doi: 10.1016/j.ejim.2013.07.005. Epub 2013 Aug 13.

PMID:
23953848
20.

RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers.

Crijns HJ, Bash LD, Chazelle F, Le Heuzey JY, Lewalter T, Lip GY, Maggioni AP, Martín A, Ponikowski P, Rosenqvist M, Sanders P, Scanavacca M, Bernhardt AA, Unniachan S, Phatak HM, Gitt AK.

BMC Cardiovasc Disord. 2012 Oct 2;12:85. doi: 10.1186/1471-2261-12-85.

21.

Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation.

Bash LD, Buono JL, Davies GM, Martin A, Fahrbach K, Phatak H, Avetisyan R, Mwamburi M.

Cardiovasc Drugs Ther. 2012 Apr;26(2):167-79. doi: 10.1007/s10557-012-6374-4. Review.

PMID:
22418856
22.

Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes.

Selvin E, Ning Y, Steffes MW, Bash LD, Klein R, Wong TY, Astor BC, Sharrett AR, Brancati FL, Coresh J.

Diabetes. 2011 Jan;60(1):298-305. doi: 10.2337/db10-1198. Epub 2010 Oct 26.

23.

Race differences in access to health care and disparities in incident chronic kidney disease in the US.

Evans K, Coresh J, Bash LD, Gary-Webb T, Köttgen A, Carson K, Boulware LE.

Nephrol Dial Transplant. 2011 Mar;26(3):899-908. doi: 10.1093/ndt/gfq473. Epub 2010 Aug 5.

24.

Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury.

Grams ME, Astor BC, Bash LD, Matsushita K, Wang Y, Coresh J.

J Am Soc Nephrol. 2010 Oct;21(10):1757-64. doi: 10.1681/ASN.2010010128. Epub 2010 Jul 29.

25.

Heart rate variability predicts ESRD and CKD-related hospitalization.

Brotman DJ, Bash LD, Qayyum R, Crews D, Whitsel EA, Astor BC, Coresh J.

J Am Soc Nephrol. 2010 Sep;21(9):1560-70. doi: 10.1681/ASN.2009111112. Epub 2010 Jul 8.

26.

Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study.

Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J.

Am J Kidney Dis. 2010 Apr;55(4):648-59. doi: 10.1053/j.ajkd.2009.12.016. Epub 2010 Feb 26.

27.

Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals.

Jaffer AK, Brotman DJ, Bash LD, Mahmood SK, Lott B, White RH.

Am J Med. 2010 Feb;123(2):141-50. doi: 10.1016/j.amjmed.2009.09.017.

PMID:
20103023
28.

Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study.

Bash LD, Astor BC, Coresh J.

Am J Kidney Dis. 2010 Jan;55(1):31-41. doi: 10.1053/j.ajkd.2009.09.006. Epub 2009 Nov 22.

PMID:
19932544
29.

Change in estimated GFR associates with coronary heart disease and mortality.

Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J.

J Am Soc Nephrol. 2009 Dec;20(12):2617-24. doi: 10.1681/ASN.2009010025. Epub 2009 Nov 5.

30.

Defining incident chronic kidney disease in the research setting: The ARIC Study.

Bash LD, Coresh J, Köttgen A, Parekh RS, Fulop T, Wang Y, Astor BC.

Am J Epidemiol. 2009 Aug 15;170(4):414-24. doi: 10.1093/aje/kwp151. Epub 2009 Jun 17.

31.

Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.

Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC.

Am J Kidney Dis. 2009 Apr;53(4):596-605. doi: 10.1053/j.ajkd.2008.10.044. Epub 2008 Dec 24.

32.

Supplemental Content

Support Center